Abn Amro Investment Solutions Regeneron Pharmaceuticals, Inc. Transaction History

Abn Amro Investment Solutions

$4.88 Trillion
Q3 2025

A detailed history of Abn Amro Investment Solutions transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Abn Amro Investment Solutions holds 6,784 shares of REGN stock, worth $4.7 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

6,784

Previous 7,638 11.18%

Holding current value

$4.7 Million

Previous $4.01 Billion 4.88%

% of portfolio

0.08%

Previous 0.08%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$534.91 - $598.71 $456,813 - $511,298	-854 Reduced 11.18%	6,784 $3.81 Billion
Q2 2025 Aug 08, 2025	BUY	$483.07 - $625.6 $3.69 Million - $4.78 Million	7,638 New	7,638 $4.01 Billion
Q1 2025 Aug 27, 2025	BUY	$634.14 - $744.83 $17.2 Million - $20.2 Million	27,102 Added 354.83%	34,740 $22 Billion
Q4 2024 Sep 04, 2025	SELL	$701.85 - $1046.91 $1.21 Million - $1.81 Million	-1,725 Reduced 4.41%	37,375 $26.6 Billion
Q3 2024 Sep 04, 2025	BUY	$1024.09 - $1201.76 $32.2 Million - $37.8 Million	31,462 Added 411.91%	39,100 $41.1 Billion
Q2 2024 Sep 04, 2025	BUY	$883.2 - $1071.19 $26.8 Million - $32.5 Million	30,316 Added 396.91%	37,954 $39.9 Billion
Q1 2024 Sep 05, 2025	BUY	$902.69 - $993.35 $14.5 Million - $16 Million	16,081 Added 66.04%	40,430 $38.9 Billion
Q4 2023 Sep 05, 2025	BUY	$775.18 - $881.7 $1.45 Million - $1.65 Million	1,871 Added 8.32%	24,349 $21.4 Billion
Q3 2023 Nov 07, 2025	BUY	$692.45 - $844.37 $10.9 Million - $13.3 Million	15,694 Added 231.34%	22,478 $18.5 Billion
Q3 2023 Nov 03, 2025	SELL	$692.45 - $844.37 $591,352 - $721,091	-854 Reduced 11.18%	6,784 $3.81 Billion
Q3 2023 Sep 05, 2025	BUY	$692.45 - $844.37 $318,527 - $388,410	460 Added 2.09%	22,478 $18.5 Billion
Q2 2023 Sep 05, 2025	BUY	$700.03 - $830.35 $3.34 Million - $3.97 Million	4,777 Added 27.71%	22,018 $15.8 Billion
Q1 2023 Sep 05, 2025	BUY	$680.49 - $826.97 $6.53 Million - $7.94 Million	9,603 Added 125.73%	17,241 $14.2 Billion

Others Institutions Holding REGN

# of Institutions

1,465

Shares Held

85.5M

Call Options Held

2.16M

Put Options Held

1.65M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abn Amro Investment Solutions, based on Form 13F filings with the SEC.

News

Stay updated on Abn Amro Investment Solutions with notifications on news.

Account

Abn Amro Investment Solutions Regeneron Pharmaceuticals, Inc. Transaction History